Breast Imaging: Page 12

Bayer secures EU clearance for contrast mammography

By AuntMinnieEurope.com staff writers

Bayer has secured European Union (EU) regulatory approval for the use of its Ultravist 300 and Ultravist 370 contrast agents for contrast-enhanced mammography examinations.

January 23, 2023

Dutch team issues positive AI results for dense breasts

By Amerigo Allegretto

An artificial intelligence (AI) system that combines mammography and ultrasound data is comparable to radiologists for detecting cancer in women with dense breasts, a group from the Netherlands Cancer Institute has found.

January 22, 2023

Report: English breast academy can boost outcomes

By AuntMinnieEurope.com staff writers

The National Breast Imaging Academy in England can help to deliver improved outcomes for patients and save the health economy around 50 million pounds (57 million euros) over 10 years, an independent evaluation report has predicted.

January 22, 2023

DWI-MRI helps breast cancer patients' chemotherapy response

By Amerigo Allegretto

Diffusion-weighted MRI (DWI-MRI) can help predict breast cancer patients' response to neoadjuvant chemotherapy, Belgian authors have reported in a study published by Nature Scientific Reports.

January 19, 2023

How equitable and universal is access to breast screening?

By Amerigo Allegretto

Mammography screening is less likely to be used by women who are part of marginalized groups, who live in rural areas, and with low-income status and education level, research published on 9 January in the European Journal of Radiology has found.

January 15, 2023

Half of DCIS-treated women don't get ongoing imaging surveillance

By Amerigo Allegretto

Nearly half of women treated for ductal carcinoma in situ (DCIS) do not consistently comply with imaging surveillance guidelines in the first five years after treatment, a Dutch study published on 10 January in Radiology suggests.

January 11, 2023

Breast MRI helps downgrade some BI-RADS 3 lesions from ultrasound

By Amerigo Allegretto

Breast MRI enables around 10% of breast lesions to be downgraded to a lower BI-RADS level and settle the need for closer follow-up, according to research published on 3 January in the European Journal of Radiology Open.

January 4, 2023

French study shows breast screening leads to higher survival rates

By Amerigo Allegretto

Women who attend organized breast cancer screening have a higher survival rate than women who attend opportunistic screening, according to research from the University of Bordeaux.

December 18, 2022

Ultrasound sheds light on axillary staging in breast cancer

By Frances Rylands-Monk

Researchers from Turkey have found that asymmetrical cortical enlargement on the side closer to the breast, abnormal microvascular pattern, and high cortex-hilum ratio are independent predictors of axillary nodal involvement.

December 13, 2022

AI can safely reduce breast imaging workload as third reader

By Amerigo Allegretto

In double-reading scenarios, artificial intelligence (AI) can reduce breast imaging workload by over one-third by replacing one reader without causing a reduction in quality, suggests new research from Sweden.

December 12, 2022

German study spells out how AI improves breast cancer detection

By Amerigo Allegretto

Artificial intelligence (AI) can help detect more cancers and be used in consensus decision-making compared with radiologists alone. That's the view of an experienced European breast imaging specialist.

December 12, 2022

Support grows for use of abbreviated MRI in breast cancer screening

By Amerigo Allegretto

Abbreviated breast MRI can serve as a viable alternative to conventional MRI when it comes to high-risk supplemental screening, suggests research presented at the RSNA annual meeting in Chicago.

December 5, 2022

Previous Page

Page 12 of 139

Next Page